Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study-Reference-Cited by-同舟云学术

Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study

Published:2024-04-13 Issue:9 Volume:103 Page:3701-3712
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Leotta Salvatore,Markovic Uros,Duminuco Andrea,Mulè Antonino,Porretto Ferdinando,Federico Vincenzo,Gentile Massimo,Pastore Domenico,Nigro Luca Lo,Selleri Carmine,Serio Bianca,Calafiore Valeria,Patti Caterina,Mauro Elisa,Vetro Calogero,Maugeri Cinzia,Parisi Marina,Fiumara Paolo,Parrinello Laura,Marino Sara,Scuderi Grazia,Garibaldi Bruno,Musso Maurizio,Renzo Nicola Di,Vigna Ernesto,Martino Enrica Antonia,Raimondo Francesco Di,Milone Giuseppe

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05725-9.pdf

Reference25 articles.

1. DeAngelo DJ, Jabbour E, Advani A (2020) Recent Advances in Managing Acute Lymphoblastic Leukemia. Am Soc Clin Oncol Educ Book. ;40:330–342. https://doi.org/10.1200/EDBK_280175. PMID: 32421447

2. Hoelzer D, Bassan R, Dombret H, Fielding A, Ribera JM, Buske C, ESMO Guidelines Committee (2016) Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(5):v69–v82. https://doi.org/10.1093/annonc/mdw025Epub 2016 Apr 7. PMID: 27056999

3. Malard F, Mohty M (2020) Acute lymphoblastic leukaemia. Lancet. ;395(10230):1146–1162. https://doi.org/10.1016/S0140-6736(19)33018-1. PMID: 32247396

4. Brüggemann M, Kotrova M (2017) Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation. Blood Adv 1(25):2456–2466. https://doi.org/10.1182/bloodadvances.2017009845PMID: 29296895; PMCID: PMC5729622

5. Lussana F, Intermesoli T, Gianni F, Boschini C, Masciulli A, Spinelli O, Oldani E, Tosi M, Grassi A, Parolini M, Audisio E, Cattaneo C, Raimondi R, Angelucci E, Cavattoni IM, Scattolin AM, Cortelezzi A, Mannelli F, Ciceri F, Mattei D, Borlenghi E, Terruzzi E, Romani C, Bassan R, Rambaldi A (2016) Achieving Molecular Remission before Allogeneic Stem Cell transplantation in adult patients with Philadelphia chromosome-positive Acute Lymphoblastic Leukemia: impact on Relapse and Long-Term Outcome. Biol Blood Marrow Transpl 22(11):1983–1987. https://doi.org/10.1016/j.bbmt.2016.07.021Epub 2016 Aug 1. PMID: 27492792